Pharmacovigilance Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Pharmacovigilance Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Pharmacovigilance Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global pharmacovigilance
  market size reached US 7.9 Billion in 2023.
• Pharmacovigilance (PV) is the pharmacological
  science of studying the detection, assessment,
  and prevention of unfavorable effects of
  pharmaceutical medicines. It plays a critical
  role in identifying previously unknown ADR
  (adverse drug reactions) and drug toxicity,
  determining changes in frequency or severity, and
  assessing the risks and benefits of drugs to
  determine required actions.
• It also assures the accuracy of communicated
  information to healthcare professionals and
  patients. As a result, PV is widely used to
  comprehend the effects of drugs on individuals
  across the globe.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/pharmacovigilance-marke
  t/requestsample

4
Report Description

• Global Pharmacovigilance Market Trends
• The market is primarily driven by the rising
  prevalence of chronic diseases, such as diabetes,
  hypertension, oncological diseases, and cardiac
  disorders, resulting in the increasing
  consumption of drugs worldwide. In addition, the
  introduction of advanced platforms to ensure
  automated ADR reporting is contributing to market
  growth. Moreover, the sudden outbreak of
  coronavirus disease (COVID-19) and the consequent
  necessity for vaccination has also created
  several opportunities for the market players.
  This, coupled with the widespread adoption of new
  technologies in clinical research, such as the
  incorporation of virtual services in the clinical
  trial protocol, is augmenting the market growth.
• Besides this, leading companies are undertaking
  various initiatives to conduct clinical trials
  and generate awareness about the proper
  utilization of medicines, which is facilitating
  the market growth. Along with this, extensive
  research and development (RD) activities
  conducted by major pharmaceutical and
  biotechnological companies to develop new drugs
  are providing a positive thrust to the market
  growth.
• Looking forward, IMARC Group expects the market
  value to reach US 15.9 Billion by 2032,
  exhibiting a CAGR of 7.8 during the forecast
  period (2024-2032).
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/pharmacovigilance-marke
  t

5
Report Segmentation

• Breakup by Service Provider
• In-house
• Contract Outsourcing
•  
• Breakup by Product Life Cycle
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
• Breakup by Type
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring

6
Report Segmentation

• EHR Mining
• Breakup by Process Flow
• Case Data Management
• Case Logging
• Case Data Analysis
• Medical Reviewing and Reporting
• Signal Detection
• Adverse Event Logging
• Adverse Event Analysis
• Adverse Event Review and Reporting
• Risk Management System
• Risk Evaluation System

7
Report Segmentation

• Risk Mitigation System
• Breakup by Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others
• Breakup by End Use
• Pharmaceuticals Companies
• Biotechnology Companies
• Medical Device Companies
• Others

8
Report Segmentation

• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

9
Competitive Landscape with Key Players

• Accenture plc
• ArisGlobal LLC
• BioClinica Inc. (Cinven Partners LLP)
• Capgemini
• Cognizant
• International Business Machines Corporation
• ICON plc.
• IQVIA Inc.
• ITClinical
• Parexel International Corporation
• Wipro Limited

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Pharmacovigilance
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Service Provider
• 6.1 In-house
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Contract Outsourcing
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Product Life Cycle
• 7.1 Pre-clinical
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

13
Table of Contents

• 7.2 Phase I
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Phase II
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Phase III
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 7.5 Phase IV
• 7.5.1 Market Trends
• 7.5.2 Market Forecast
• 8 Market Breakup by Type
• 8.1 Spontaneous Reporting
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Intensified ADR Reporting
• 8.2.1 Market Trends
• 8.2.2 Market Forecast

14
Partial List of Clients
15
Partial List of Clients
16
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

17
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us